Evofem Biosciences's total assets for Q4 2025 were $20.27M, an increase of 46.84% from the previous quarter. EVFM total liabilities were $89.71M for the fiscal quarter, a 6.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.